2. Adverse Event Associated with Turmeric Preparation : Consumer Reporting Experiences by Mrs. Wimon Suwankesawong Thai Adverse Product Reaction Monitoring Center Food and Drug Administration Thailand

3.  Turmeric, Curcuma longa Linn., is a herbal plant extensively cultivated in Thailand Introduction (1)  Its rhizome is used in traditional medicines for many indications  Major chemical constituents of rhizomes are volatile oil (6%) and curcumenoids(5%)

4.  In 1999,the single formulation of turmeric was selected as herbal medicine for the Thai National Essential Drug list for anti-flatulence - 250 mg powder of dried turmeric rhizome Introduction (2)

5.  Turmeric is believed to be effective and safe  adverse effect : nausea, vomiting diarrhea constipation, pruritus, headache, dizziness, palpitation  Curcumin, an active ingredient in turmeric, has been reported to induce gastric ulceration in rats Introduction (3)

6. Objective  To investigate and categorize adverse events associated with turmeric preparations Study design  Prospective time-series design

7. Method (1)  Setting  Fifty government hospitals  Study population  Patients who prescribed turmeric product during April 1, 2001-March 30,2003

8. Data collection  Hospital pharmacist interviewed the patients to collect baseline data  Patients were asked to send back a postcard with formalized questions after 1-2 weeks to report their experience using turmeric products  Effective  Adverse event Method (2)

9. Result (1)  Patients taking turmeric product= 978  Lost follow up= 342 (34.96%)  Study population= 636  Patient with adverse event= 220 (34.59%)  Female= 158 (71.8%)  Mean age = 48  Underlying disease= 126  Number of adverse events= 479

10. Results (2) AEs : System-organ classes n=479 (%) GI system disorders186 (38.83)  abdominal pain, n/v, anorexia, diarrhea Body as a whole-general 148 (30.90) disorders  fatigue, chest discomfort, therapeutic response decreased(ineffective)

11. Results (3) AEs : System-organ classes n=479 (%) Central & peripheral nervous 51 (10.82) system disorder  headache, dizziness Respiratory system disorders 48 (10.02)  dyspnoea,cough Skin and appendages disorders 32 (0.84)  rash, pruritus

12. Discussion  Lost of follow up  Direct consumer reporting system  Mild adverse event  GI system disorder  Volatile oil : stomach distress  Follow up period : 2 week (too short)  Quality of products : ineffective  Compliance : low

13. Conclusion  Single turmeric product : safe  GI system disorder  Further study  GI system disorder associated with single turmeric preparation  Labeled on product insert